Leveraging Explainable Artificial Intelligence (XAI) for Expert Interpretability in Predicting Rapid Kidney Enlargement Risks in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Autosomal dominant polycystic kidney disease (ADPKD) is the predominant hereditary factor leading to end-stage renal disease (ESRD) worldwide, affecting individuals across all races with a prevalence of 1 in 400 to 1 in 1000. The disease presents significant challenges in management, particularly wi...
| Published in: | AI |
|---|---|
| Main Authors: | Latifa Dwiyanti, Hidetaka Nambo, Nur Hamid |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-2688/5/4/100 |
Similar Items
Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update
by: Matt Gittus, et al.
Published: (2025-02-01)
by: Matt Gittus, et al.
Published: (2025-02-01)
Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease
by: Dorothee Oberdhan, et al.
Published: (2024-01-01)
by: Dorothee Oberdhan, et al.
Published: (2024-01-01)
The Relationship Between Dietary Intakes and Total Kidney Volume in Patients with Autosomal Dominant Polycystic Kidney Disease Dietary Intake and Polycystic Kidney Volume
by: Yonca Sevim, et al.
Published: (2022-09-01)
by: Yonca Sevim, et al.
Published: (2022-09-01)
Metformin as a Disease-Modifying Agent in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review of Preclinical and Clinical Evidence
by: Aleksandra Maciejczyk, et al.
Published: (2025-09-01)
by: Aleksandra Maciejczyk, et al.
Published: (2025-09-01)
Clinical findings, underlying pathogenetic processes and treatment of vascular dysfunction in autosomal dominant polycystic kidney disease
by: Jinjun Zhu, et al.
Published: (2023-12-01)
by: Jinjun Zhu, et al.
Published: (2023-12-01)
Clinical Manifestation, Management and Prognosis of Acute Myocardial Infarction in Autosomal Dominant Polycystic Kidney Disease
by: Bo Yang, et al.
Published: (2018-11-01)
by: Bo Yang, et al.
Published: (2018-11-01)
Systems biology approaches toward autosomal dominant polycystic kidney disease (ADPKD)
by: Ilnaz Rahimmanesh, et al.
Published: (2020-01-01)
by: Ilnaz Rahimmanesh, et al.
Published: (2020-01-01)
Supporting complexity: the psychologist’s role in multidisciplinary management of polycystic kidney disease
by: Sara Farinone, et al.
Published: (2024-04-01)
by: Sara Farinone, et al.
Published: (2024-04-01)
Prenatal Diagnosis of Autosomal Dominant Polycystic Kidney Disease: Case Report
by: Elitsa Gyokova, et al.
Published: (2025-04-01)
by: Elitsa Gyokova, et al.
Published: (2025-04-01)
Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Role in Cystogenesis and Novel Therapeutic Approaches
by: Jingyuan Gao, et al.
Published: (2025-06-01)
by: Jingyuan Gao, et al.
Published: (2025-06-01)
Applying a Deep Learning Model for Total Kidney Volume Measurement in Autosomal Dominant Polycystic Kidney Disease
by: Jia-Lien Hsu, et al.
Published: (2024-09-01)
by: Jia-Lien Hsu, et al.
Published: (2024-09-01)
A case of pulmonary embolism caused by compression of the vena cava by intra‐abdominal masses in autosomal polycystic kidney disease
by: Christopher Holzmann‐Littig, et al.
Published: (2020-07-01)
by: Christopher Holzmann‐Littig, et al.
Published: (2020-07-01)
Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) During Pregnancy: Risks and Challenges
by: McBride L, et al.
Published: (2020-05-01)
by: McBride L, et al.
Published: (2020-05-01)
Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing
by: Othman R. Alzahrani, et al.
Published: (2022-11-01)
by: Othman R. Alzahrani, et al.
Published: (2022-11-01)
A novel heterozygous PKD1 variant causing alternative splicing in a Chinese family with autosomal dominant polycystic kidney disease
by: Qianying Zhao, et al.
Published: (2023-08-01)
by: Qianying Zhao, et al.
Published: (2023-08-01)
Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers
by: Iva Sorić Hosman, et al.
Published: (2023-11-01)
by: Iva Sorić Hosman, et al.
Published: (2023-11-01)
AUTOSOMAL – DOMINANT POLYCYSTIC KIDNEY DISEASE – A GLEAM OF HOPE?
by: V.V. Doretskyi, et al.
Published: (2014-01-01)
by: V.V. Doretskyi, et al.
Published: (2014-01-01)
Evaluating gene variations in autosomal dominant polycystic kidney disease patients using whole exome sequencing and phenotype to genotype analysis
by: Hande Aypek, et al.
Published: (2025-12-01)
by: Hande Aypek, et al.
Published: (2025-12-01)
Clinical and genetic study of a Chinese family affected by both amyotrophic lateral sclerosis and autosomal dominant polycystic kidney disease
by: Shirong Li, et al.
Published: (2022-10-01)
by: Shirong Li, et al.
Published: (2022-10-01)
Effects of tolvaptan discontinuation in patients with autosomal dominant polycystic kidney disease: a post hoc pooled analysis
by: Michael Lioudis, et al.
Published: (2023-06-01)
by: Michael Lioudis, et al.
Published: (2023-06-01)
Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling
by: Xia Zhou, et al.
Published: (2022-09-01)
by: Xia Zhou, et al.
Published: (2022-09-01)
Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy
by: Degli Esposti L, et al.
Published: (2017-04-01)
by: Degli Esposti L, et al.
Published: (2017-04-01)
Intracranial aneurysms in autosomal dominant polycystic kidney disease
by: Jung Hyun Park
Published: (2024-12-01)
by: Jung Hyun Park
Published: (2024-12-01)
Tolvaptan: a possible preemptive treatment option in children with autosomal dominant polycystic kidney disease?
by: Hee Sun Beak, et al.
Published: (2023-12-01)
by: Hee Sun Beak, et al.
Published: (2023-12-01)
Effectiveness of tolvaptan on renal replacement therapy in patients with autosomal dominant polycystic kidney disease: a retrospective cohort study from the TriNetX global collaborative network
by: Ming-Ju Wu, et al.
Published: (2024-12-01)
by: Ming-Ju Wu, et al.
Published: (2024-12-01)
Femoral Neuropathy Secondary to Autosomal Dominant Polycystic Kidney Disease: A Case Report
by: Jeehyun Yoo, et al.
Published: (2018-06-01)
by: Jeehyun Yoo, et al.
Published: (2018-06-01)
Results of kidney transplantation in patients with end-stage renal failure caused by autosomal dominant polycystic kidney disease
by: V. S. Daineko, et al.
Published: (2019-07-01)
by: V. S. Daineko, et al.
Published: (2019-07-01)
Endovascular Management of Renal Artery Pseudoaneurysm in Autosomal Dominant Polycystic Kidney Disease: A Case Report
by: Garima Sharma, et al.
Published: (2024-10-01)
by: Garima Sharma, et al.
Published: (2024-10-01)
Perspectives of Patients and Clinicians on Reproductive Health Care and ADPKD
by: Margriet E. Gosselink, et al.
Published: (2024-11-01)
by: Margriet E. Gosselink, et al.
Published: (2024-11-01)
Progression to kidney failure in ADPKD: the PROPKD score underestimates the risk assessed by the Mayo imaging classification
by: Daniela Maria Allmer, et al.
Published: (2024-11-01)
by: Daniela Maria Allmer, et al.
Published: (2024-11-01)
Bone health in autosomal dominant polycystic kidney disease (ADPKD) patients after kidney transplantation
by: Dalia Zubidat, et al.
Published: (2023-06-01)
by: Dalia Zubidat, et al.
Published: (2023-06-01)
Update on the Application of Ultrasonography in Understanding Autosomal Dominant Polycystic Kidney Disease
by: Wen-Chin Lee, et al.
Published: (2024-04-01)
by: Wen-Chin Lee, et al.
Published: (2024-04-01)
Polycystic Kidney Disease–Related Disease Burden in Adolescents With Autosomal Dominant Polycystic Kidney Disease: An International Qualitative StudyPlain-Language Summary
by: Dorothee Oberdhan, et al.
Published: (2022-03-01)
by: Dorothee Oberdhan, et al.
Published: (2022-03-01)
LAPAROSCOPIC NEPHRECTOMY IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
by: O. N. Reznik, et al.
Published: (2016-11-01)
by: O. N. Reznik, et al.
Published: (2016-11-01)
Participant Perceptions of Increasing Water Intake in Polycystic Kidney Disease
by: Sneha Amin, et al.
Published: (2025-07-01)
by: Sneha Amin, et al.
Published: (2025-07-01)
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) IN A LARGE IRANIAN FAMILY
by: D.D. Farhud, et al.
Published: (1999-08-01)
by: D.D. Farhud, et al.
Published: (1999-08-01)
Autosomal dominant polycystic kidney disease with ectopic unilateral multicystic kidney: a case report
by: Yaw Amoah, et al.
Published: (2024-01-01)
by: Yaw Amoah, et al.
Published: (2024-01-01)
Evaluating the Efficacy and Safety of Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Mohamed Ibrahim, et al.
Published: (2025-01-01)
by: Mohamed Ibrahim, et al.
Published: (2025-01-01)
Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?
by: Stéphanie De Rechter, et al.
Published: (2017-12-01)
by: Stéphanie De Rechter, et al.
Published: (2017-12-01)
Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease
by: Yaerim Kim, et al.
Published: (2023-05-01)
by: Yaerim Kim, et al.
Published: (2023-05-01)
Similar Items
-
Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update
by: Matt Gittus, et al.
Published: (2025-02-01) -
Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease
by: Dorothee Oberdhan, et al.
Published: (2024-01-01) -
The Relationship Between Dietary Intakes and Total Kidney Volume in Patients with Autosomal Dominant Polycystic Kidney Disease Dietary Intake and Polycystic Kidney Volume
by: Yonca Sevim, et al.
Published: (2022-09-01) -
Metformin as a Disease-Modifying Agent in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review of Preclinical and Clinical Evidence
by: Aleksandra Maciejczyk, et al.
Published: (2025-09-01) -
Clinical findings, underlying pathogenetic processes and treatment of vascular dysfunction in autosomal dominant polycystic kidney disease
by: Jinjun Zhu, et al.
Published: (2023-12-01)
